Emerging Nondopaminergic Medications for Parkinson’s Disease: Focusing on A2A Receptor Antagonists and GLP1 Receptor Agonists

Emerging Nondopaminergic Medications for Parkinson’s Disease: Focusing on A2A Receptor Antagonists and GLP1 Receptor Agonists

Parkinson’s disease (PD) is a severe neurodegenerative disease characterized by classic motor features associated with the loss of dopaminergic neurons and appearance of Lewy bodies in the substantia nigra. Due to the complexity of PD, a definitive diagnosis in the early stages and effective managem...

Full description

Bibliographic Details
Main Authors: Pei Shang, Matthew Baker, Samantha Banks, Sa-Ik Hong, Doo-Sup Choi
Format: Article
Language:English
Published: Korean Movement Disorder Society 2021-09-01
Series:Journal of Movement Disorders
Subjects:
a2a receptor antagonist
glp1 receptor agonist
parkinson’s disease
Online Access:http://www.e-jmd.org/upload/jmd-21035.pdf

Similar Items

Similar Items